Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Gugliucci

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Pharmacological Reports : PR|December 20, 2011
Influence of ezetimibe monotherapy on ischemia-modified albumin levels in hypercholesterolemic patientsKazuhiko Kotani, Russell Caccavello, Naoki Sakane, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 6, 2012
Enzymatic assessment of paraoxonase 1 activity on HDL subclasses: a practical zymogram method to assess HDL functionAlejandro Gugliucci, Russell Caccavello, Kazuhiko Kotani, et al.
Diabetology & Metabolic Syndrome|July 28, 2010
Serum aspirin esterase is strongly associated with glucose and lipids in healthy subjects: different association patterns in subjects with type 2 diabetes mellitusKazuhiko Kotani, Satoshi Kimura, Tetsu Ebara, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 16, 2005
Ischemia-modified albumin levels in cord blood: a case-control study in uncomplicated and complicated deliveriesAlejandro Gugliucci, Ricardo Hermo, Carolina Monroy, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 20, 2009
The free fraction of paraoxonase 1 is not increased in patients with end stage renal disease undergoing hemodialysisAlejandro Gugliucci, John Schulze, Eriko Kinugasa, et al.
Clinical Chemistry and Laboratory Medicine|October 22, 2010
Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysisAlejandro Gugliucci, Eriko Kinugasa, Kazuhiko Kotani, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 4, 2014
Activation of paraoxonase 1 after hemodialysis is associated with HDL remodeling and its increase in the HDL2 fraction and VLDLAlejandro Gugliucci, Eriko Kinugasa, Hiroaki Ogata, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 15, 2020
Higher ANGPTL3, apoC-III, and apoB48 dyslipidemia, and lower lipoprotein lipase concentrations are associated with dysfunctional visceral fat in adolescents with obesityReyna Rodríguez-Mortera, Russell Caccavello, Ma Eugenia Garay-Sevilla, et al.
Planta Medica|September 8, 2007
Protective action of Ilex paraguariensis extract against free radical inactivation of paraoxonase-1 in high-density lipoproteinTeresita Menini, Caleb Heck, John Schulze, et al.
Thescientificworldjournal|December 31, 2014
Correlation of ischemia-modified albumin with SOFA and APACHE II scores in preoperative patients with colorectal cancerMasaaki Satoh, Kazuhiko Kotani, Alejandro Gugliucci, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Pharmacological Reports : PR|December 20, 2011
Influence of ezetimibe monotherapy on ischemia-modified albumin levels in hypercholesterolemic patientsKazuhiko Kotani, Russell Caccavello, Naoki Sakane, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 6, 2012
Enzymatic assessment of paraoxonase 1 activity on HDL subclasses: a practical zymogram method to assess HDL functionAlejandro Gugliucci, Russell Caccavello, Kazuhiko Kotani, et al.
Diabetology & Metabolic Syndrome|July 28, 2010
Serum aspirin esterase is strongly associated with glucose and lipids in healthy subjects: different association patterns in subjects with type 2 diabetes mellitusKazuhiko Kotani, Satoshi Kimura, Tetsu Ebara, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 16, 2005
Ischemia-modified albumin levels in cord blood: a case-control study in uncomplicated and complicated deliveriesAlejandro Gugliucci, Ricardo Hermo, Carolina Monroy, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 20, 2009
The free fraction of paraoxonase 1 is not increased in patients with end stage renal disease undergoing hemodialysisAlejandro Gugliucci, John Schulze, Eriko Kinugasa, et al.
Clinical Chemistry and Laboratory Medicine|October 22, 2010
Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysisAlejandro Gugliucci, Eriko Kinugasa, Kazuhiko Kotani, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 4, 2014
Activation of paraoxonase 1 after hemodialysis is associated with HDL remodeling and its increase in the HDL2 fraction and VLDLAlejandro Gugliucci, Eriko Kinugasa, Hiroaki Ogata, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 15, 2020
Higher ANGPTL3, apoC-III, and apoB48 dyslipidemia, and lower lipoprotein lipase concentrations are associated with dysfunctional visceral fat in adolescents with obesityReyna Rodríguez-Mortera, Russell Caccavello, Ma Eugenia Garay-Sevilla, et al.
Planta Medica|September 8, 2007
Protective action of Ilex paraguariensis extract against free radical inactivation of paraoxonase-1 in high-density lipoproteinTeresita Menini, Caleb Heck, John Schulze, et al.
Thescientificworldjournal|December 31, 2014
Correlation of ischemia-modified albumin with SOFA and APACHE II scores in preoperative patients with colorectal cancerMasaaki Satoh, Kazuhiko Kotani, Alejandro Gugliucci, et al.
Pageof 10